Anne Wojcicki, co-founder and CEO of 23andMe, discusses her company's dramatic decline from a booming genetic testing pioneer to facing significant financial challenges. Rolfe Winkler, a Wall Street Journal reporter, sheds light on the implications of a recent data breach and the company's struggle to monetize wellness products. They explore ethical concerns surrounding genetic data use, the emotional impact of DNA revelations, and the broader significance of consumer genetics in healthcare innovation. The conversation uncovers both the potential and pitfalls of personal genomics.
